Skip to main content
. 2025 May 28;25:962. doi: 10.1186/s12885-025-14374-8

Table 6.

Molecular type of patients with BC according to CSCO consensus in 2019

Molecular type Death (n) Survive (n) Total (n) Death rate (%) median Ki-67 index (%) χ2 P
Luminal A 15 75 90 16.67% 11.23%
Luminal B HER-2 (-) 7 29 36 19.44% 37.7%
Luminal B HER-2 (+) 9 33 42 21.43% 23.84%
Over-expression HER-2 type 15 28 43 34.88% 31.10% 5.53 0.019
Triple-negative type 12 27 39 30.77% 35.32%

※ Luminal A type vs. HER-2 over-expression type